Breaking News Instant updates and real-time market news.

MDSO

Medidata

$79.90

-0.35 (-0.44%)

, PVTB

PrivateBancorp

04:55
06/26/17
06/26
04:55
06/26/17
04:55

Medidata to replace PrivateBancorp in S&P 400 at open on 6/26

Canadian Imperial Bank of Commerce is acquiring PrivateBancorpin a deal expected to be completed on June 23.

MDSO

Medidata

$79.90

-0.35 (-0.44%)

PVTB

PrivateBancorp

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

  • 12

    Jul

MDSO Medidata
$79.90

-0.35 (-0.44%)

04/27/17
NEED
04/27/17
NO CHANGE
Target $75
NEED
Buy
Medidata price target raised to $75 from $65 at Needham
Needham analyst Scott Berg raised his price target for Medidata to $75 from $65 after the company reported what he believes to be its strongest quarter in several years, hitting a trifecta of sustained over 20% revenue growth, margin leverage, and bookings commentary above expectations. The analyst reiterates a Buy rating on the shares.
05/01/17
JEFF
05/01/17
UPGRADE
Target $63
JEFF
Hold
Medidata upgraded to Hold from Underperform at Jefferies
Jefferies analyst David Windley upgraded Medidata Solutions to Hold citing increased confidence in the company's growth targets. Channel checks suggest competitive displacements and increasing deal size should drive sustained high-teens to 20% revenue growth, the analyst contends. He raised his price target for the shares to $63 from $47.
06/06/17
BOFA
06/06/17
INITIATION
Target $85
BOFA
Buy
Medidata initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Steven Valiquette initiated Medidata Solutions with a Buy and an $85 price target saying it has established itself as a lading provider of cloud-based clinical trial data capture with robust growth.
06/12/17
KEYB
06/12/17
NO CHANGE
KEYB
Medidata to benefit from growth of risk-based monitoring, says KeyBanc
KeyBanc says that industry guidelines recently adopted by the EU should be a catalyst for risk-based monitoring technologies, or RBM. The firm says that Medidiata is the HCT it covers which is most exposed to RBM. It thinks that the company's revenue from RBM has reached a $50M annual run rate, while further adoption of RBM should accelerate adoption of its other SaaS tools. KeyBanc raised its price target on the stock to $84 from $83 and keeps an Overweight rating on the shares.
PVTB PrivateBancorp

06/30/16
06/30/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on the today's top five analyst downgrades with this list compiled by The Fly: 1. Diamond Resorts (DRII) downgraded to Neutral from Buy at Goldman by analyst Steven Kent after the company agreed to be acquired by Apollo Global Management (APO) for $30.25 per share. The analyst keeps his price target of $32 for the shares. MKM Partners also downgraded Diamond Resorts to Neutral from Buy. 2. Qualcomm (QCOM) downgraded to Market Perform from Outperform by Bernstein, which kept a $55 target on the stock. The firm thinks that estimates for the company's September quarter remain too high, due to unrealistic licensing expectations. Bernstein adds that the company has long-term "structural issues." 3. TESARO (TSRO) downgraded to Hold from Buy at Jefferies by analyst Eun Yang, citing yesterday's rally on the company's positive Phase 3 data for niraparib in ovarian cancer. The data were better than expected, but so was the stock move, Yang tells investors in a research note. The analyst prefers a Hold rating ahead of the full data set as well as competitor data in the second half of 2016 and 2017. She lists a potential takeout and competitor data not being as good as niraparib as risks to her downgrade. Yang raised her price target for TESARO shares to $75 from $53.4. PrivateBancorp (PVTB) downgraded to Market Perform from Outperform at Keefe Bruyette by analyst David Long following the acquisition by CIBC (CM) saying he does not expected a competing bid to come to the table. PrivateBancorp was also downgraded to Market Perform from Outperform at Keefe Bruyette. 5. Spirit AeroSystems (SPR) downgraded to Market Perform from Outperform at Wells Fargo by analyst Sam Pearlstein, saying a charge for the A350 could make multiple expansion difficult. Spirit could be close to finishing a revised A350 pricing agreement that, when completed, could trigger a reach-forward loss accrual of around $200M, Pearlstein says. The analyst lowered his price target range for the shares to $50-$55 from $55-$60.This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/27/17
KBWI
03/27/17
UPGRADE
Target $63
KBWI
Outperform
PrivateBancorp upgraded to Outperform from Market Perform at Keefe Bruyette
Keefe Bruyette analyst Christopher McGratty upgraded PrivateBancorp to Outperform and raised his price target for the shares to $63 from $54.
03/31/17
BARD
03/31/17
NO CHANGE
Target $61
BARD
Neutral
CIBC raised offer should seal PrivateBancorp deal, says Baird
Baird analyst David George believes CIBC's (CM) increased bid for PrivateBancorp (PVTB) should satisfy investor objections to prior terms and makes shareholder approval likely. He increased his price target on PrivateBancorp to $61 from $55 and keeps a Neutral rating on the shares. Industry consolidation should pick up over time, but George noted he does not expect a near-term increase in larger regional bank M&A.
05/30/17
KBWI
05/30/17
DOWNGRADE
Target $63
KBWI
Market Perform
PrivateBancorp downgraded to Market Perform from Outperform at Keefe Bruyette
Keefe Bruyette analyst Christopher McGratty downgraded PrivateBancorp to Market Perform citing the pending takeover by CIBC. The analyst has a $63 price target for the shares.

TODAY'S FREE FLY STORIES

ABX

Barrick Gold

$16.92

-0.38 (-2.20%)

07:40
09/19/17
09/19
07:40
09/19/17
07:40
Conference/Events
Barrick Gold management to meet with Deutsche Bank »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Oct

07:40
09/19/17
09/19
07:40
09/19/17
07:40
General news
Treasury Market Outlook: yields are a little lower »

Treasury Market Outlook:…

SFTBF

SoftBank

$78.30

0.3501 (0.45%)

07:39
09/19/17
09/19
07:39
09/19/17
07:39
Periodicals
SoftBank Ventures Korea looks to invest in promising start-ups, CNBC says »

SoftBank Ventures Korea,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCK

McKesson

$148.42

-1.46 (-0.97%)

07:38
09/19/17
09/19
07:38
09/19/17
07:38
Initiation
McKesson initiated  »

McKesson initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 27

    Sep

SUPN

Supernus

$49.65

0.6 (1.22%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Downgrade
Supernus rating change  »

Supernus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

HSIC

Henry Schein

$80.90

-1.98 (-2.39%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Initiation
Henry Schein initiated  »

Henry Schein initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$68.34

0.26 (0.38%)

07:36
09/19/17
09/19
07:36
09/19/17
07:36
Recommendations
CarMax analyst commentary  »

CarMax price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

PTLA

Portola Pharmaceuticals

$56.57

1.62 (2.95%)

07:36
09/19/17
09/19
07:36
09/19/17
07:36
Periodicals
Portola blood thinner launch could be complicated by guidelines, STAT News says »

The commercial launch of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

CRL

Charles River

$107.29

1.27 (1.20%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Initiation
Charles River initiated  »

Charles River initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$85.84

1.04 (1.23%)

, BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Hot Stocks
Post Holdings to acquire Bob Evans for $77.00 per share »

Post Holdings (POST) and…

POST

Post Holdings

$85.84

1.04 (1.23%)

BOBE

Bob Evans

$72.93

1.02 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$170.01

-1.63 (-0.95%)

, AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Periodicals
FB design head touts voice command, stays silent on hardware, TechCrunch says »

Facebook (FB) head of…

FB

Facebook

$170.01

-1.63 (-0.95%)

AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

GOOG

Alphabet

$915.00

-5.29 (-0.57%)

GOOGL

Alphabet Class A

$929.75

-5.54 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

OA

Orbital ATK

$132.25

22.21 (20.18%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Downgrade
Orbital ATK rating change  »

Orbital ATK downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$187.55

7.44 (4.13%)

, FCX

Freeport McMoRan

$14.13

0.25 (1.80%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

NVDA

Nvidia

$187.55

7.44 (4.13%)

FCX

Freeport McMoRan

$14.13

0.25 (1.80%)

WFC

Wells Fargo

$52.71

1.05 (2.03%)

V

Visa

$104.83

-0.47 (-0.45%)

HIMX

Himax

$10.70

0.15 (1.42%)

COP

ConocoPhillips

$47.09

0.58 (1.25%)

STX

Seagate

$33.52

-0.03 (-0.09%)

MOS

Mosaic

$21.31

0.65 (3.15%)

TMUS

T-Mobile

$61.80

0.63 (1.03%)

FCAU

Fiat Chrysler

$16.82

0.16 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 12

    Oct

  • 29

    Nov

  • 15

    Jan

ESRX

Express Scripts

$62.01

-0.64 (-1.02%)

, ANTM

Anthem

$185.00

-1.59 (-0.85%)

07:34
09/19/17
09/19
07:34
09/19/17
07:34
Initiation
Express Scripts, Anthem initiated  »

Express Scripts initiated…

ESRX

Express Scripts

$62.01

-0.64 (-1.02%)

ANTM

Anthem

$185.00

-1.59 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 25

    Oct

WBS

Webster Financial

$48.71

0.73 (1.52%)

07:33
09/19/17
09/19
07:33
09/19/17
07:33
Hot Stocks
Webster Financial announces CEO succession »

Webster Financial's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

AAPL

Apple

$158.67

-1.21 (-0.76%)

07:32
09/19/17
09/19
07:32
09/19/17
07:32
Recommendations
Apple analyst commentary  »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$16.99

-1.11 (-6.13%)

07:32
09/19/17
09/19
07:32
09/19/17
07:32
Hot Stocks
Teva completes amendment to credit facilities »

Teva Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

CTLT

Catalent

$39.90

0.41 (1.04%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31
Hot Stocks
Catalent to acquire Cook Pharmica for $950M »

Catalent announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$10.80

-0.4 (-3.57%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31
Initiation
Mirati Therapeutics initiated  »

Mirati Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

POST

Post Holdings

$85.84

1.04 (1.23%)

, BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Post Holdings, Bob Evans »

Post Holdings to acquire…

POST

Post Holdings

$85.84

1.04 (1.23%)

BOBE

Bob Evans

$72.93

1.02 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRI

Itron

$76.50

3.7 (5.08%)

, SSNI

Silver Spring

$16.10

3.1 (23.85%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Downgrade
Itron, Silver Spring rating change  »

Itron downgraded to Hold…

ITRI

Itron

$76.50

3.7 (5.08%)

SSNI

Silver Spring

$16.10

3.1 (23.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Hot Stocks
Breaking Hot Stocks news story on Bob Evans »

Bob Evans trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.42

0.32 (0.86%)

, CRM

Salesforce

$95.74

1.11 (1.17%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

T

AT&T

$37.42

0.32 (0.86%)

CRM

Salesforce

$95.74

1.11 (1.17%)

AXON

Axovant Sciences

$22.88

1.54 (7.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 29

    Nov

Q

QuintilesIMS

$95.07

0.6 (0.64%)

07:29
09/19/17
09/19
07:29
09/19/17
07:29
Initiation
QuintilesIMS initiated  »

QuintilesIMS initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$24.35

1.77 (7.84%)

07:27
09/19/17
09/19
07:27
09/19/17
07:27
Recommendations
Meritor analyst commentary  »

Meritor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.